Novo Nordisk (NVO) US Chief says twice as many medicare patients prefer GLP-1 pill to shot; seeking bolt-on M&A to boost portfolio

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

BoC MInutes: Agreed that monetary policy will need to remain nimble

ECB's Zigman says main goal is price stability

Novo Nordisk (NVO) US Chief says twice as many medicare patients prefer GLP-1 pill to shot; seeking bolt-on M&A to boost portfolio

US President Trump says Iran is making big concessions and its going very well

US sells USD 70bln of 5yr notes; tails 0.7bps

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free